Department of Kinesiology and Nutrition, University of Illinois, Chicago, IL, USA.
Mov Disord. 2013 Aug;28(9):1230-40. doi: 10.1002/mds.25380. Epub 2013 Mar 27.
The effects of progressive resistance exercise (PRE) on the motor signs of Parkinson's disease have not been studied in controlled trials. The objective of the current trial was to compare 6-, 12-, 18-, and 24-month outcomes of patients with Parkinson's disease who received PRE with a stretching, balance, and strengthening exercise program. The authors conducted a randomized controlled trial between September 2007 and July 2011. Pairs of patients matched by sex and off-medication scores on the Unified Parkinson's Disease Rating Scale, motor subscale (UPDRS-III), were randomly assigned to the interventions with a 1:1 allocation ratio. The PRE group performed a weight-lifting program. The modified fitness counts (mFC) group performed a stretching, balance, and strengthening exercise program. Patients exercised 2 days per week for 24 months at a gym. A personal trainer directed both weekly sessions for the first 6 months and 1 weekly session after 6 months. The primary outcome was the off-medication UPDRS-III score. Patients were followed for 24 months at 6-month intervals. Of 51 patients, 20 in the PRE group and 18 in the mFC group completed the trial. At 24 months, the mean off-medication UPDRS-III score decreased more with PRE than with mFC (mean difference, -7.3 points; 95% confidence interval, -11.3 to -3.6; P<0.001). The PRE group had 10 adverse events, and the mFC group had 7 adverse events. PRE demonstrated a statistically and clinically significant reduction in UPDRS-III scores compared with mFC and is recommended as a useful adjunct therapy to improve Parkinsonian motor signs. © 2013 Movement Disorder Society.
抗阻运动对帕金森病运动症状的影响尚未在对照试验中进行研究。本试验的目的是比较接受抗阻运动(举重)与伸展、平衡和力量训练(mFC)的帕金森病患者在 6、12、18 和 24 个月时的结果。作者于 2007 年 9 月至 2011 年 7 月进行了一项随机对照试验。将按性别和“统一帕金森病评定量表(UPDRS),运动评分(UPDRS-III)”停药评分匹配的患者对以 1:1 的比例随机分配至干预组。抗阻运动组进行举重训练,mFC 组进行伸展、平衡和力量训练。患者每周进行 2 次,为期 24 个月,在健身房进行。一名私人教练在前 6 个月每周指导 2 次,在 6 个月后每周指导 1 次。主要结局指标为停药 UPDRS-III 评分。患者每 6 个月随访 1 次,共随访 24 个月。51 例患者中,抗阻运动组 20 例,mFC 组 18 例完成试验。24 个月时,与 mFC 组相比,抗阻运动组的停药后 UPDRS-III 评分降低更多(平均差值,-7.3 分;95%置信区间,-11.3 至-3.6;P<0.001)。抗阻运动组有 10 例不良事件,mFC 组有 7 例不良事件。与 mFC 相比,抗阻运动组的 UPDRS-III 评分有显著统计学和临床意义的降低,建议将其作为改善帕金森病运动症状的有用辅助治疗方法。 © 2013 运动障碍学会。
Neurorehabil Neural Repair. 2015-2
Med Sci Sports Exerc. 2016-9
Eur J Phys Rehabil Med. 2017-3-13
Front Sports Act Living. 2025-6-2
J Mov Disord. 2025-7
Front Aging Neurosci. 2024-12-24
J Parkinsons Dis. 2024
N Engl J Med. 2012-2-9
Parkinsons Dis. 2011-11-24
Neurorehabil Neural Repair. 2011-12-2
Mov Disord. 2010-11-15
J Strength Cond Res. 2010-11
Hum Brain Mapp. 2010-3-11